Nayak SM - Search Results

1

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Raison CL, et al. Among authors: nayak sm. JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530. JAMA. 2023. PMID: 37651119 Free PMC article.

2

Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.

Gukasyan N, Nayak SM. Gukasyan N, et al. Among authors: nayak sm. Transcult Psychiatry. 2022 Oct;59(5):652-664. doi: 10.1177/1363461520983684. Epub 2021 Jan 26. Transcult Psychiatry. 2022. PMID: 33499762

3

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.

Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS. Yaden DB, et al. Int J Neuropsychopharmacol. 2021 Aug 20;24(8):615-623. doi: 10.1093/ijnp/pyab026. Int J Neuropsychopharmacol. 2021. PMID: 33987652 Free PMC article. Review.

4

Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.

Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Nayak SM, et al. Pharmacopsychiatry. 2021 Sep;54(5):240-245. doi: 10.1055/a-1524-2794. Epub 2021 Aug 4. Pharmacopsychiatry. 2021. PMID: 34348413

5

The Potential of Psychedelics for End of Life and Palliative Care.

Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. Yaden DB, et al. Among authors: nayak sm. Curr Top Behav Neurosci. 2022;56:169-184. doi: 10.1007/7854_2021_278. Curr Top Behav Neurosci. 2022. PMID: 34958455 Review.

6

A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities.

Nayak SM, Griffiths RR. Nayak SM, et al. Front Psychol. 2022 Mar 28;13:852248. doi: 10.3389/fpsyg.2022.852248. eCollection 2022. Front Psychol. 2022. PMID: 35418909 Free PMC article.

7

Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.

Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR. Sweeney MM, et al. PLoS One. 2022 Aug 24;17(8):e0271926. doi: 10.1371/journal.pone.0271926. eCollection 2022. PLoS One. 2022. PMID: 36001643 Free PMC article.

8

Belief changes associated with psychedelic use.

Nayak SM, Singh M, Yaden DB, Griffiths RR. Nayak SM, et al. J Psychopharmacol. 2023 Jan;37(1):80-92. doi: 10.1177/02698811221131989. Epub 2022 Nov 1. J Psychopharmacol. 2023. PMID: 36317643

9

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.

Gukasyan N, Griffiths RR, Yaden DB, Antoine DG 2nd, Nayak SM. Gukasyan N, et al. Among authors: nayak sm. J Psychopharmacol. 2023 Jul;37(7):707-716. doi: 10.1177/02698811231179910. Epub 2023 Jun 8. J Psychopharmacol. 2023. PMID: 37291890

10

Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.

Davis AK, Timmermann C, Ortiz Bernal AM, Lancelotta R, Nayak S, Sepeda ND, Nikolaidis A, Griffiths RR. Davis AK, et al. J Psychoactive Drugs. 2023 Jul 14:1-11. doi: 10.1080/02791072.2023.2232379. Online ahead of print. J Psychoactive Drugs. 2023. PMID: 37449499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page